Investigating a Model for Acute Ischemic Pain in Humans
NCT ID: NCT02192242
Last Updated: 2014-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2007-06-30
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..
NCT01200524
IV Lidocaine Infusion for Neuropathic Pain
NCT05731739
First-In-Human PainCart Study for STR-324
NCT03430232
Interaction Between NGF and Acute Exercise-induced Ischemia
NCT03470038
Understanding Risk Factors and Determinants for Neuropathic Pain
NCT02402361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute ischemic pain
acute ischemic pain was induced by treadmill testing in all patients investigated
acute ischemic pain
acute ischemic pain was induced by treadmill exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acute ischemic pain
acute ischemic pain was induced by treadmill exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* unilateral femoral-popliteal PAD, Fontaine grade II
Exclusion Criteria
* diabetic polyneuropathy
* deep vein thrombosis
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Philip Lang
Attending physician, Assistant Professor of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip M Lang, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesiology, Ludwig-Maximilians-University Munich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Munich, Pettenkoferstr. 8a
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.